News & Articles
Top 5 Considerations For CAR-T Trials During A Macroeconomic Downturn
Navigating CAR-T cell therapy trials during economic downturns requires strategic approaches to […]
Read More....Modernize TMF Culture to Better Support Modern Clinical Trials
The article focuses on the need to modernize Trial Master File (TMF) […]
Read More....Identifying The Best People To Run A Clinical Study (And How To Hire Them)
The article emphasizes the importance of identifying and hiring top talent to […]
Read More....Great Size ≠ Great Value: How Smaller Outsourcing Partners Benefit Small And Emerging Biotechs
The article highlights the advantages of partnering with smaller outsourcing firms for […]
Read More....What Big CROs Don’t Want You To Know About Staffing Scalability For Phase III Studies
The article addresses the hidden challenges of staffing scalability in Phase III […]
Read More....The Fallacy of the Corporate Memory Concept
The article challenges the concept of “corporate memory” within large CROs, arguing […]
Read More....Do You Take Comfort In Governance Agreements
The article delves into the limitations of governance agreements with large CROs, […]
Read More....Keys to Successful Risk Management in Clinical Trials
The article emphasizes the critical role of comprehensive risk management in clinical […]
Read More....The Great Talent Misconception With Large CROs
The article examines the misconception that large contract research organizations (CROs) offer […]
Read More....Natural History Studies in Gene Therapy Trials: Benefits, Timing and Execution
Natural history studies (NHS) in gene therapy trials are essential for understanding […]
Read More....